Alzheimer disease trials in Belgium
17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleInRAD Observational Study
- Where
- Leuven
- Age
- 18 years and over
- People
- 50,000 worldwide
- Run by
- Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
See details and how to joinNCT07213700 - Phase 2Taking peopleStudy to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
- Where
- Gent, Jette, Kortrijk, Leuven, Sint-Lambrechts-Woluwe
- Age
- 50 years to 90 years
- People
- 450 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07781657 · EU 2026-526158-14-00 - No phaseNot yet taking people in BelgiumUltra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's Disease
- Where
- Leuven
- Age
- 18 years and over
- People
- 70
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07906054 - Phase 3Taking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Alken, Jette, Kortrijk, Roeselare
- Age
- 55 years to 90 years
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - Phase 2Taking peopleA Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Where
- Kortrijk, Leuven, Sint-Lambrechts-Woluwe
- Age
- 50 years to 85 years
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07033494 · EU 2024-519190-19-00 - Phase 3Taking peopleOpen-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Where
- Alken, Jette, Kortrijk, Roeselare
- Age
- 55 years to 90 years
- People
- 1,000 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT05980949 · EU 2023-504151-27-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
- Where
- Hasselt, Leuven, Roeselare
- Age
- 55 years to 90 years
- People
- 500 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06126224 · EU 2023-504416-16-00 - No phaseTaking peopleBlood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.
- Where
- Leuven
- Age
- 55 years to 85 years
- People
- 240
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07666113 - No phaseEnrolling by invitationComparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
- Where
- Leuven
- Age
- 28 days and over
- People
- 1,600
- Run by
- prof. dr. Koen Van Laere
See details and how to joinNCT07595666 - No phaseTaking peopleUltra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
- Where
- Leuven
- Age
- 18 years to 90 years
- People
- 300
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07509125 - Phase 1Taking peopleQuantification of Hsp90 in the Human Brain
- Where
- Leuven
- Age
- 18 years to 70 years
- People
- 48
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07380204 · EU 2023-510532-36-00 - No phaseEnrolling by invitationEFFECT OF PERIODONTAL TREATMENT ON ALZHEIMER DISEASE-ASSOCIATED OUTCOMES
- Where
- Liège
- People
- 26
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT07233512 - No phaseNot yet taking people in BelgiumSleep Stimulation to Enhance Waste Clearance in the Brain
- Where
- Brussels
- Age
- 18 years to 80 years
- People
- 105
- Run by
- Erasme University Hospital
See details and how to joinNCT07051239 - Phase 2/3Taking people[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
- Where
- Ghent, Leuven
- Age
- 18 years to 85 years
- People
- 113
- Run by
- prof. dr. Koen Van Laere
See details and how to joinNCT06120049 - No phaseTaking peopleHormone Replacement Trial Against ALzheimers' Disease
- Where
- Ghent
- Age
- 40 years to 65 years
- People
- 600
- Run by
- University Hospital, Ghent
See details and how to joinNCT04312399 - Phase 4Taking peopleCognitive brain circuits and the spread of tau in vivo in humans
- Where
- Leuven
- Age
- 18 years and over
- People
- 160
- Run by
- UZ Leuven
See details and how to join2024-511613-38-01 · EU 2024-511613-38-01 - No phaseTaking peopleSpatial Navigation for the Early Detection of Alzheimer's Disease.
- Where
- Ghent
- Age
- 50 years to 80 years
- People
- 160
- Run by
- University Hospital, Ghent
See details and how to joinNCT06385951